166 related articles for article (PubMed ID: 34950098)
1. Recurrent Anti-AMPA Receptor Limbic Encephalitis: A Case Report and Literature Review.
Fang Y; Pan D; Huang H
Front Neurol; 2021; 12():735983. PubMed ID: 34950098
[TBL] [Abstract][Full Text] [Related]
2. An Uncommon Presentation of a Primary Bone Tumor: Anti-AMPA (Anti-α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid) Receptor Limbic/Paraneoplastic Encephalitis as a Presenting Feature of Ewing Sarcoma.
Koh D; Lau T; Teoh E; Lau KK
J Pediatr Hematol Oncol; 2018 Oct; 40(7):555-557. PubMed ID: 30247289
[TBL] [Abstract][Full Text] [Related]
3. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy in limbic encephalitis with anti-glutamate receptor antibodies: Case report and systematic literature review.
Wei YC; Huang CC; Liu CH; Kuo HC; Lin JJ
Brain Behav; 2017 Sep; 7(9):e00779. PubMed ID: 28948076
[TBL] [Abstract][Full Text] [Related]
5. First Reported Case of Anti-Ampa Receptor Encephalitis in a Vietnamese Adolescent.
Trung Hieu NL; Minh Duc N; Tra My TT; Hieu Anh B; Tan Lien Bang M; Minh Thong P
Clin Med Insights Case Rep; 2021; 14():11795476211037782. PubMed ID: 34408524
[TBL] [Abstract][Full Text] [Related]
6. Rapid progression and brain atrophy in anti-AMPA receptor encephalitis.
Wei YC; Liu CH; Lin JJ; Lin KJ; Huang KL; Lee TH; Chang YJ; Peng TI; Lin KL; Chang TY; Chang CH; Kuo HC; Chang KH; Cheng MY; Huang CC
J Neuroimmunol; 2013 Aug; 261(1-2):129-33. PubMed ID: 23796872
[TBL] [Abstract][Full Text] [Related]
7. Hashimoto's encephalitis associated with AMPAR2 antibodies: a case report.
Zhu M; Yu X; Liu C; Duan C; Li C; Zhu J; Zhang Y
BMC Neurol; 2017 Feb; 17(1):37. PubMed ID: 28222692
[TBL] [Abstract][Full Text] [Related]
8. Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.
Joubert B; Kerschen P; Zekeridou A; Desestret V; Rogemond V; Chaffois MO; Ducray F; Larrue V; Daubail B; Idbaih A; Psimaras D; Antoine JC; Delattre JY; Honnorat J
JAMA Neurol; 2015 Oct; 72(10):1163-9. PubMed ID: 26280228
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and prognosis of anti-alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor encephalitis.
Zhang Z; Fan S; Ren H; Zhou L; Guan H
BMC Neurol; 2021 Dec; 21(1):490. PubMed ID: 34915865
[TBL] [Abstract][Full Text] [Related]
10. The Peculiar Clinical Symptoms and Treatment of Limbic Encephalitis Associated with AMPA Receptor Antibody.
Jia Y; Li M; Wang H; Zhang M; Wang Y
Eur Neurol; 2021; 84(3):206-211. PubMed ID: 33857949
[TBL] [Abstract][Full Text] [Related]
11. Limbic encephalitis associated with antibodies against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor: a case report.
Zhu H; Hou YB; Gao JG; Zhao T; Zhou CK; Liu JY
Neuro Endocrinol Lett; 2018 May; 39(2):85-87. PubMed ID: 30183201
[TBL] [Abstract][Full Text] [Related]
12. Seronegative limbic encephalitis manifesting as subacute amnestic syndrome: a case report and review of the literature.
Ismail II; Alnaser F; Al-Hashel JY
J Med Case Rep; 2021 Mar; 15(1):130. PubMed ID: 33757596
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characterization of Definite Autoimmune Limbic Encephalitis: A 30-case Series.
Shojima Y; Nishioka K; Watanabe M; Jo T; Tanaka K; Takashima H; Noda K; Okuma Y; Urabe T; Yokoyama K; Hattori N
Intern Med; 2019 Dec; 58(23):3369-3378. PubMed ID: 31434821
[TBL] [Abstract][Full Text] [Related]
14. Patient characteristics and outcome associations in AMPA receptor encephalitis.
Laurido-Soto O; Brier MR; Simon LE; McCullough A; Bucelli RC; Day GS
J Neurol; 2019 Feb; 266(2):450-460. PubMed ID: 30560455
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune Encephalitis Associated with Anti-gamma-aminobutyric Acid B Receptor Antibodies Mimicking Syncope.
Kitazaki Y; Ikawa M; Yamaguchi T; Enomoto S; Kishitani T; Shirafuji N; Hayashi K; Yamamura O; Nakamoto Y; Hamano T
Intern Med; 2020 Mar; 59(6):843-847. PubMed ID: 31813910
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune Encephalitis With Psychotic Manifestations and Cognitive Impairment Presenting as Schizophrenia: Case Report and Literature Review.
Luo Y; Li J; Jiang F; Tan A; Qin X; Xiao X; Wang Z; Wang P; Yi Y; Li J; Yuan S; Liu L; Xiao J
Front Psychiatry; 2022; 13():827138. PubMed ID: 35237195
[TBL] [Abstract][Full Text] [Related]
17. Fulminant anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR1 antibodies encephalitis in a Chinese boy: a case report.
Han W; Ma J; Jiang L; Cheng M
BMC Pediatr; 2022 May; 22(1):287. PubMed ID: 35581601
[TBL] [Abstract][Full Text] [Related]
18. Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy.
Kishitani T; Matsunaga A; Ikawa M; Hayashi K; Yamamura O; Hamano T; Watanabe O; Tanaka K; Nakamoto Y; Yoneda M
Medicine (Baltimore); 2017 Mar; 96(10):e6181. PubMed ID: 28272206
[TBL] [Abstract][Full Text] [Related]
19. Rapidly progressive neurological deterioration in anti-AMPA receptor encephalitis with additional CRMP5 antibodies.
Yang S; Qin J; Li J; Gao Y; Zhao L; Wu J; Song B; Xu Y; Sun S
Neurol Sci; 2016 Nov; 37(11):1853-1855. PubMed ID: 27465029
[TBL] [Abstract][Full Text] [Related]
20. Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report.
Luo Q; Wu X; Huang W
BMC Neurol; 2019 Jun; 19(1):126. PubMed ID: 31195997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
